Active, not recruitingPhase 3NCT04336722
Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)
Studying Isolated biliary atresia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Albireo, an Ipsen Company
- Principal Investigator
- Ipsen Medical DirectorIpsen
- Intervention
- Odevixibat(drug)
- Enrollment
- 254 enrolled
- Eligibility
- All sexes
- Timeline
- 2020 – 2026
Study locations (30)
- Children's Hospital Los Angeles, Los Angeles, California, United States
- Stanford Children's Health, Palo Alto, California, United States
- Rady Children's Hospital, San Diego, California, United States
- UCSF Benioff Children's Hospital San Francisco, San Francisco, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- Nemours/Alfred I. duPont Hospital for Children, Wilmington, Delaware, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- University of Miami, Miami, Florida, United States
- Children's Healthcare of Atlanta - Emory University School of Medicine, Atlanta, Georgia, United States
- Ann & Robert H. Lurie Children's Hospital, Chicago, Illinois, United States
- Indiana University school of Medicine, Indianapolis, Indiana, United States
- Johns Hopkins Children's Center, Baltimore, Maryland, United States
- Boston Children's Hospital, Boston, Massachusetts, United States
- University of Michigan Children's Hospital, Ann Arbor, Michigan, United States
- Children's Mercy Hospital, Kansas City, Missouri, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04336722 on ClinicalTrials.govOther trials for Isolated biliary atresia
Additional recruiting or active studies for the same condition.
- RECRUITINGEARLY PHASE1NCT07250854The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal CholestasisUniversity of Alabama at Birmingham
- RECRUITINGNANCT06764082Nutritional Intervention for Biliary AtresiaTongji Hospital
- RECRUITINGNANCT06564740Stem Cell Applications in Biliary Atresia PatientsNecmi Kadıoğlu Hospital
- ACTIVE NOT RECRUITINGNCT06184971Biliary Atresia Research Network NortheastYale University
- RECRUITINGNCT05848310Preoperative Serum FGF19 in the Prognosis of Biliary AtresiaChildren's Hospital of Fudan University
- RECRUITINGNANCT05925309Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai PortoenterostomyChildren's Hospital of Fudan University
- ENROLLING BY INVITATIONPHASE3NCT05426733An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary AtresiaAlbireo, an Ipsen Company
- RECRUITINGNCT05072626High Medium-chain Triglyceride Nutritional Support in Infants With Biliary AtresiaChildren's Hospital of Fudan University